We advise clinicians to consider HEY2 as a causative gene in patients with unsolved cardiovascular defects. If a potentially deleterious variant in HEY2 is identified, clinical follow-up and genetic screening of family members is warranted, as HEY2 perturbation can lead to critical cardiac defects.
HEY2